ANGELA BALLARD: Open Payments
NPI 1154673986 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,191 in 123 payments from 19 companies in 2025. Trend: 2023 $1,054 · 2024 $2,066 · 2025 $2,191
Food & beverage: $2,111Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $420 |
| UCB, Inc. | 14 | $265 |
| ABBVIE INC. | 13 | $260 |
| Lilly USA, LLC | 13 | $209 |
| E.R. Squibb & Sons, L.L.C. | 23 | $201 |
| Novartis Pharmaceuticals Corporation | 14 | $185 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| Incyte Corporation | 4 | $91 |
| Amgen Inc. | 4 | $74 |
| Arcutis Biotherapeutics, Inc. | 4 | $68 |
Products named: TREMFYA, Bimzelx, SKYRIZI, Sotyktu, TALTZ, DUPIXENT, COSENTYX, OPZELURA.
Industry payments across KY — which companies pay providers there.
